IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA
October 17, 2012
CINDA MCLAUGHLIN, PLAINTIFF,
GLAXOSMITHKLINE, L.L.C., CADILA HEALTHCARE, ZYDUS PHARMACEUTICALS, AND APOTEX, INC. DEFENDANT.
The opinion of the court was delivered by: Ronald L. Buckwalter, S.J.
ORDER AND NOW, this 17thday of October, 2012, upon consideration of (1) the Motion by Defendant GlaxoSmithKline, LLC. to Transfer Venue to the United States District Court for the Western District of Louisiana (Docket No. 7), the Response in Opposition by Plaintiff Cinda McLaughlin (Docket No. 20), Plaintiff's Supplemental Response in Opposition (Docket No. 25), Defendant's Reply Brief in Support (Docket No. 29), and Plaintiff's Sur-Reply Brief in Opposition (Docket No. 38); and (2) Plaintiff's Motions to Voluntarily Dismiss Defendants Cadila Healthcare, Zydus Pharmaceuticals, and Apotex Inc. (Docket Nos. 34--36), it is hereby ORDERED as follows:
1. All claims against Defendants Cadila Healthcare, Zydus Pharmaceuticals, and Apotex Inc. are hereby DISMISSED without prejudice.
2. Defendant's Motion to Transfer is GRANTED. This case shall be TRANSFERRED to the United States District Court for the Western District of Louisiana.
BY THE COURT:
Ronald L. Buckwalter
© 1992-2012 VersusLaw Inc.